Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Hemogenyx Pharma (OTC : HOPHF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Hemogenyx Pharmaceuticals PLC and its subsidiary is a preclinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.
Quote
| Last: | $2.33 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $2.33 |
| Close: | $2.33 |
| High: | $2.33 |
| Low: | $2.33 |
| Volume: | 3,647 |
| Last Trade Date Time: | 07/23/2025 12:20:37 pm |
Stock Data
| Market Cap: | $74,085,821 |
|---|---|
| Float: | 3,036,298 |
| Insiders Ownership: | 12.2% |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.hemogenyx.com |
| Country: | GB |
| City: | London |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Hemogenyx Pharma (OTC: HOPHF).
